Development and Validation of Spectrophotometric Method for Estimation of Levosulpiride in Bulk and Tablet Dosage Form
 
More details
Hide details
1
Rayat-Bahra Institute of Pharmacy, INDIA
CORRESPONDING AUTHOR
Rajesh Kumar   

Rayat-Bahra Institute of Pharmacy, Hoshiarpur, India
Online publication date: 2016-12-20
Publication date: 2016-12-20
 
Eurasian J Anal Chem 2017;12(3):265–273
 
KEYWORDS
TOPICS
ABSTRACT
A simple, accurate, precise and economical spectrophotometric method has been developed for estimation of Levosulpiride in bulk form as well as marketed formulations. The estimation of Levosulpiride was done at 291.2 nm in pH 6.8 phosphate buffer using UV-Visible double beam spectrophotometer. In the developed method, linearity over the concentration range of 10-100µg/ml of Levosulpiride was observed and was found in agreement of Beer’s law. The linear regression was found to be 0.999. The results of analysis have been validated statistically and recovery studies confirmed the accuracy of the proposed method. The precision (intra-day & inter-day) of method was found within limits (RSD < 2%). The sensitivity of the method was assessed by determining limit of detection and limit of quantification. The percentage of Levosulpiride in the marketed formulation (LEFIT-50) was observed to be 99.46%. It could be concluded from the results obtained in the present investigation that the method for estimation of Levosulpiride in pure form and in pharmaceutical dosage form is simple, rapid, accurate, precise and economical and can be used, successfully, in the quality control of pharmaceutical formulations and other routine laboratory analysis.
 
REFERENCES (12)
1.
The Martindale: The complete drug reference, 35th Edition. (2006). London, UK: Pharmaceutical press.
 
2.
The Merck Index: An Encyclopedia of Chemicals Drug and Biologicals, 10th Edition. (2006). Merck & Co. Inc.
 
3.
Padmalatha, M., Snehalatha, T., Ramya, S., & Kanakadurga, M. (2012). A simple and validated RP-HPLC method for the simultaneous estimation of rabeprazole and levosulpiride in bulk and pharmaceutical dosage forms. Int R J Pharm App Sci, 2, 99-106.
 
4.
Mucci, A., Nolfe. G., & Maj, M. (1995). Levosulpiride, A review of its clinical use in psychiatry. Pharmacol Res, 31, 95‐101.
 
5.
Lozano, R., Concham M. P., Montealegre, A., Leon, A., Villalba, J. O., & Esteban, H. et al. (2007). Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia. Therap Clin Risk Management, 3, 149-155.
 
6.
Manjunath, S., Chouhan, V., & Sandeep, S. (2011). Spectrophotometric estimation of levosulpiride in bulk drug and Formulations. Int J Pharmacy Pharm Sci, 3, 135-137.
 
7.
ICH, Harmonized Tripartite Guideline, Validation of Analytical Procedures, Text and Methodology Q2 (R1). (2004).
 
8.
Monika, L. J., Manoj, V. G., Shripad, K. T., & Manish, S. J. (2014). Development and Validation of Spectrophotometric Methods for Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form. Int J Spec, 1-6.
 
9.
Sneha, G. N., Jaivik, V. S., Priyanka, A. S., Mallika, S., & Pranav, S. S. (2015). Spectrophotometric Determination of Five Commercial Drugs in Pure Form and Pharmaceutical Formulations by Ion-Pair Complexation with Alizarin Red S. Eurasian J Anal Chem, 10, 68-83.
 
10.
Deulgaonkar, Y. B., Patel, J. A, Mahajan, M. P., & Sawant, S. D. (2013). UV spectrophotometric method for simultaneous estimation of rabeprazole sodium and levosulpiride in bulk and tablet dosage form. Der Pharma Chemica, 3, 163-168.
 
11.
Nazir, I., Abbas, J., & Asad, M. (2013). Formulation and in vitro Evaluation of Orodispersible tablet of Levosulpiride. J Pharm Cosm Sci, 4, 53-56.
 
12.
Kothapalli, L. P., Inamdar, A. A., Nanda, R. K., & Thomas, A. B. (2014). Development and validation of a stability indicating RP-HPLC method for simultaneous estimation of Pantoprazole sodium sesquihydrate and Levosulpiride in a combined dosage form. Int J Res Pharm Sci, 4, 32-38.
 
eISSN:1306-3057